(A) Survival curves of PFDN1 (Affymetrix IDs: 201507_at), PFDN2 (Affymetrix IDs: 218336_at), PFDN3 (VBP1, Affymetrix IDs: 201472_at), PFDN4 (Affymetrix IDs: 205362_s_at), PFDN5 (Affymetrix IDs: 210908_s_at), PFDN6 (Affymetrix IDs: 233588_x_at) in M0 subset; (B) survival curves of PFDN1 (Affymetrix IDs: 201507_at), PFDN2 (Affymetrix IDs: 218336_at), PFDN3 (VBP1, Affymetrix IDs: 201472_at), PFDN4 (Affymetrix IDs: 205362_s_at), PFDN5 (Affymetrix IDs: 210908_s_at), PFDN6 (Affymetrix IDs: 233588_x_at) in LN+ subset. Red: high mRNA expression; black: low mRNA expression. (C) The expression levels of PFDN members in GC patients from Ruijin cohort. (D) Survival analysis of PFDN members in Ruijin cohort. P-values were as indicated.
Sign In or Create an Account